Skip to main content

Advertisement

Log in

Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury

  • Review
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Electronic cigarettes (e-cigarettes) are battery-operated devices to insufflate nicotine or other psychoactive e-liquid aerosols. Despite initial claims of e-cigarettes as a nicotine-cessation device, aggressive marketing of e-cigarettes has led to an explosion in adolescents’ and young adults’ use over the last few years. Coupled with a lack of adequate investigation and regulation of e-cigarettes, the USA is facing an outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) starting in mid-2019. While little long-term health hazard data are available, the components and constituents of e-cigarettes may adversely impact health. Propylene glycol and glycerin are humectants (water-retaining excipients) that generate pulmonary irritants and carcinogenic carbonyl compounds (e.g., formaldehyde, acetaldehyde, and acrolein) when heated in e-cigarettes. Metals contained in heating coils and cartridge casings may leach metals such as aluminum, chromium, iron, lead, manganese, nickel, and tin. Flavoring agents are considered safe for ingestion but lack safety data for inhalational exposures. Diacetyl, a common buttery flavoring agent, has known pulmonary toxicity with inhalational exposures leading to bronchiolitis obliterans. In 2019, clusters of lung injury associated with e-cigarette use were identified in Wisconsin and Illinois. Patients with EVALI present with a constellation of respiratory, gastrointestinal, and constitutional symptoms. Radiographically, patients have bilateral ground glass opacifications. As of February 18, 2020, the Centers for Disease Control has identified 2807 hospitalized patients diagnosed with either “confirmed” or “probable” EVALI in the US. Currently, vitamin E acetate (VEA) used as a diluent in tetrahydrocannabinol vape cartridges is implicated in EVALI. VEA cuts tetrahydrocannabinol oil without changing the appearance or viscosity. When inhaled, pulmonary tissue lacks the mechanism to metabolize and absorb VEA, which may lead to its accumulation. While most EVALI patients were hospitalized, treatment remains largely supportive, and use of corticosteroids has been associated with clinical improvement. The outbreak of EVALI highlights the need for regulation of e-cigarette devices and e-liquids. Clinicians need to be aware of the health hazards of e-cigarettes and be vigilant in asking about vaping.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. Center for Disease Control and Prevention. 2019. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. Accessed 20 Feb 2020.

  2. Bao W, Liu B, Du Y, Snetselaar LG, Wallace RB. Electronic cigarette use among young, middle-aged, and older adults in the United States in 2017 and 2018. JAMA Intern Med. 2019. https://doi.org/10.1001/jamainternmed.2019.4957.

  3. Jamal A, Gentzke A, Hu SS, Cullen KA, Apelberg BJ, Homa DM, et al. Tobacco use among middle and high school students - United States, 2011–2016. MMWR Morb Mortal Wkly Rep. 2017;66(23):597–603. https://doi.org/10.15585/mmwr.mm6623a1.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Schulenbeg JE, Johnston LD, O’Malley PM, Bachman JG, Miech R, Patrick ME. Monitoring the future national survey results on drug use, 1975–2017. Ann Arbor: Institute for Social Research, The University of Michigan; 2018.

    Google Scholar 

  5. Eaton DL, Kwan LY, Stratton K, editors. Public health consequences of E-cigarettes. Washington DC: The National Academies Press; 2018.

    Google Scholar 

  6. Monitoring the future survey: high school and youth trends. national institute on drug abuse. National Institute on Drug Abuse. 2018. https://www.drugabuse.gov/publications/drugfacts/monitoring-future-survey-high-school-youth-trends. Accessed 20 Oct 2019.

  7. Miech R, Johnston L, O'Malley PM, Bachman JG, Patrick ME. Trends in adolescent vaping, 2017-2019. N Engl J Med. 2019;381(15):1490–1. https://doi.org/10.1056/NEJMc1910739.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Creamer MR, Wang TW, Babb S, Cullen KA, Day H, Willis G, et al. Tobacco product use and cessation indicators among adults - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(45):1013–9. https://doi.org/10.15585/mmwr.mm6845a2.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Walley SC, Wilson KM, Winickoff JP, Groner J. A public health crisis: electronic cigarettes, vape, and JUUL. Pediatrics. 2019;143(6). https://doi.org/10.1542/peds.2018-2741.

  10. Gilman G. Analytical testing of e-cigarette aerosol. In: Farsalinos KE, Gillman IG, Thornburg JW, Hecht SS, Polosa R, editors. Analytical assessment of E-cigarettes: from contents to chemical and particle exposure profiles. Amsterdam: Elsevier; 2017. p. 9–35.

    Chapter  Google Scholar 

  11. Petrucci RH, Harwood WS, Herring FG. General chemistry : principles and modern applications. 8th ed. Prentice Hall: Upper Saddle River; 2002.

    Google Scholar 

  12. Protano C, Avino P, Manigrasso M, Vivaldi V, Perna F, Valeriani F, et al. Environmental electronic vape exposure from four different generations of electronic cigarettes: airborne particulate matter levels. Int J Environ Res Public Health. 2018;15(10). https://doi.org/10.3390/ijerph15102172.

  13. Kosmider L, Sobczak A, Fik M, Knysak J, Zaciera M, Kurek J, et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;16(10):1319–26. https://doi.org/10.1093/ntr/ntu078.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Pankow JF, Kim K, McWhirter KJ, Luo W, Escobedo JO, Strongin RM, et al. Benzene formation in electronic cigarettes. PLoS One. 2017;12(3):e0173055. https://doi.org/10.1371/journal.pone.0173055.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Eddingsaas N, Pagano T, Cummings C, Rahman I, Robinson R, Hensel E. Qualitative analysis of E-liquid emissions as a function of flavor additives using two aerosol capture methods. Int J Environ Res Public Health. 2018;15(2). https://doi.org/10.3390/ijerph15020323.

  16. NextGenerationLabs. TFN. 2019. https://www.nextgenerationlabs.com. Accessed 29 Oct 2019.

  17. Nasrin S, Chen G, Watson CJ, Lazarus P. Evaluation of tobacco-specific nitrosamine (TSNA) content in smokeless tobacco products in Bangladesh. FASEB J. 2019;33(1_supplement):672.7–.7. https://doi.org/10.1096/fasebj.2019.33.1_supplement.672.7.

    Article  Google Scholar 

  18. Romberg AR, Miller Lo EJ, Cuccia AF, Willett JG, Xiao H, Hair EC, et al. Patterns of nicotine concentrations in electronic cigarettes sold in the United States, 2013-2018. Drug Alcohol Depend. 2019;203:1–7. https://doi.org/10.1016/j.drugalcdep.2019.05.029.

    Article  PubMed  Google Scholar 

  19. Bowen A, Xing C, inventors; Juul Labs Inc, assignee. Nicotine salt formulations for aerosol devices and methods thereof. United States patent 2014–0345631-A1. 2015 October 28.

  20. Yingst JM, Hrabovsky S, Hobkirk A, Trushin N, Richie JP Jr, Foulds J. Nicotine absorption profile among regular users of a pod-based electronic nicotine delivery system. JAMA Netw Open. 2019;2(11):e1915494. https://doi.org/10.1001/jamanetworkopen.2019.15494.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wu J. E-cigarette sales slowing, led by Juul, amid negative headlines. CNBC. 2019. https://www.cnbc.com/2019/10/01/e-cigarette-sales-slowing-led-by-juul-amid-negative-headlines.html. Accessed 15 Dec 2019.

  22. Wang B, Liu S, Persoskie A. Poisoning exposure cases involving e-cigarettes and e-liquid in the United States. Clin Toxicol (Phila). 2010-2018;2019:1–7. https://doi.org/10.1080/15563650.2019.1661426.

    Article  CAS  Google Scholar 

  23. Eggleston W, Nacca N, Stork CM, Marraffa JM. Pediatric death after unintentional exposure to liquid nicotine for an electronic cigarette. Clin Toxicol (Phila). 2016;54(9):890–1. https://doi.org/10.1080/15563650.2016.1207081.

    Article  Google Scholar 

  24. Child Nicotine Poisoning Prevention Act of 2015, S.142. Sect. 114th Congress (2015).

  25. Regan AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the ‘e-cigarette’ in the USA. Tob Control. 2013;22(1):19–23. https://doi.org/10.1136/tobaccocontrol-2011-050044.

    Article  PubMed  Google Scholar 

  26. Vardavas CI, Filippidis FT, Agaku IT. Determinants and prevalence of e-cigarette use throughout the European Union: a secondary analysis of 26 566 youth and adults from 27 countries. Tob Control. 2015;24(5):442–8. https://doi.org/10.1136/tobaccocontrol-2013-051394.

    Article  PubMed  Google Scholar 

  27. Zosel A, Egelhoff E, Heard K. Severe lactic acidosis after an iatrogenic propylene glycol overdose. Pharmacotherapy. 2010;30(2):219. https://doi.org/10.1592/phco.30.2.219.

    Article  PubMed  PubMed Central  Google Scholar 

  28. ATSDR. Toxicological profile for propylene glycol. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 1997.

    Google Scholar 

  29. Wieslander G, Norback D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med. 2001;58(10):649–55. https://doi.org/10.1136/oem.58.10.649.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Tang MS, Wu XR, Lee HW, Xia Y, Deng FM, Moreira AL, et al. Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice. Proc Natl Acad Sci U S A. 2019;116(43):21727–31. https://doi.org/10.1073/pnas.1911321116.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Chaumont M, van de Borne P, Bernard A, Van Muylem A, Deprez G, Ullmo J, et al. Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials. Am J Physiol Lung Cell Mol Physiol. 2019;316(5):L705–L19. https://doi.org/10.1152/ajplung.00492.2018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hahn J, Monakhova YB, Hengen J, Kohl-Himmelseher M, Schussler J, Hahn H, et al. Electronic cigarettes: overview of chemical composition and exposure estimation. Tob Induc Dis. 2014;12(1):23. https://doi.org/10.1186/s12971-014-0023-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Etter JF, Bugey A. E-cigarette liquids: Constancy of content across batches and accuracy of labeling. Addict Behav. 2017;73:137–43. https://doi.org/10.1016/j.addbeh.2017.05.012.

    Article  PubMed  Google Scholar 

  34. Varlet V, Farsalinos K, Augsburger M, Thomas A, Etter JF. Toxicity assessment of refill liquids for electronic cigarettes. Int J Environ Res Public Health. 2015;12(5):4796–815. https://doi.org/10.3390/ijerph120504796.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Morean ME, Kong G, Camenga DR, Cavallo DA, Krishnan-Sarin S. High school students’ use of electronic cigarettes to vaporize Cannabis. Pediatrics. 2015;136(4):611–6. https://doi.org/10.1542/peds.2015-1727.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Struble CA, Ellis JD, Lundahl LH. Beyond the bud: emerging methods of Cannabis consumption for youth. Pediatr Clin N Am. 2019;66(6):1087–97. https://doi.org/10.1016/j.pcl.2019.08.012.

    Article  Google Scholar 

  37. Valentine GW, Jatlow PI, Coffman M, Nadim H, Gueorguieva R, Sofuoglu M. The effects of alcohol-containing e-cigarettes on young adult smokers. Drug Alcohol Depend. 2016;159:272–6. https://doi.org/10.1016/j.drugalcdep.2015.12.011.

    Article  CAS  PubMed  Google Scholar 

  38. Lisko JG, Lee GE, Kimbrell JB, Rybak ME, Valentin-Blasini L, Watson CH. Caffeine concentrations in coffee, tea, chocolate, and energy drink flavored E-liquids. Nicotine Tob Res. 2017;19(4):484–92. https://doi.org/10.1093/ntr/ntw192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Mulder HA, Patterson JL, Halquist MS, Kosmider L, Turner JBM, Poklis JL, et al. The effect of electronic cigarette user modifications and E-liquid adulteration on the particle size profile of an aerosolized product. Sci Rep. 2019;9(1):10221. https://doi.org/10.1038/s41598-019-46387-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kenne DR, Fischbein RL, Tan AS, Banks M. The use of substances other than nicotine in electronic cigarettes among college students. Subst Abus. 2017;11:1178221817733736. https://doi.org/10.1177/1178221817733736.

    Article  Google Scholar 

  41. Huang LL, Baker HM, Meernik C, Ranney LM, Richardson A, Goldstein AO. Impact of non-menthol flavours in tobacco products on perceptions and use among youth, young adults and adults: a systematic review. Tob Control. 2017;26(6):709–19. https://doi.org/10.1136/tobaccocontrol-2016-053196.

    Article  PubMed  Google Scholar 

  42. Safety assessment and regulatory authority to use flavors: focus on e-cigarettes. Flavors and Extracts Manufacturers’ Association. 2014. https://www.femaflavor.org/node/24344. Accessed 25 Nov 2019.

  43. Criteria for a recommended standard: occupational exposure to diacetyl and 2,3-pentanedione. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH); 2016.

  44. Allen JG, Flanigan SS, LeBlanc M, Vallarino J, MacNaughton P, Stewart JH, et al. Flavoring chemicals in E-cigarettes: diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored E-cigarettes. Environ Health Perspect. 2016;124(6):733–9. https://doi.org/10.1289/ehp.1510185.

    Article  CAS  PubMed  Google Scholar 

  45. Farsalinos KE, Gillman IG, Thornburg JW, Hecht SS, Polosa R. Analytical assessment of e-cigarettes : from contents to chemical and particle exposure profiles. Emerging issues in analytical chemistry. Amsterdam: Elsevier; 2017.

    Google Scholar 

  46. Nie B, Henion J, Ryona I. The role of mass spectrometry in the Cannabis industry. J Am Soc Mass Spectrom. 2019;30(5):719–30. https://doi.org/10.1007/s13361-019-02164-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Olmedo P, Goessler W, Tanda S, Grau-Perez M, Jarmul S, Aherrera A, et al. Metal concentrations in e-cigarette liquid and aerosol samples: the contribution of metallic coils. Environ Health Perspect. 2018;126(2):027010. https://doi.org/10.1289/EHP2175.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Williams M, Bozhilov K, Ghai S, Talbot P. Elements including metals in the atomizer and aerosol of disposable electronic cigarettes and electronic hookahs. PLoS One. 2017;12(4):e0175430. https://doi.org/10.1371/journal.pone.0175430.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Lee MS, Allen JG, Christiani DC. Endotoxin and (1,3)-β-D-glucan contamination in electronic cigarette products sold in the United States. Environ Health Perspect. 2019;127(4):47008. https://doi.org/10.1289/EHP3469.

    Article  PubMed  Google Scholar 

  50. Tobacco 21 Laws: Raising the minimum sales age for all tobacco products to 21. American Lung Association. 2020. https://www.lung.org/our-initiatives/tobacco/cessation-and-prevention/tobacco-21-laws.html. Accessed 21 Feb 2020.

  51. FDA finalizes enforcement policy on unauthorized flavored cartridge-based e-cigarettes that appeal to children, including fruit and mint. U.S. Food & Drug Administration. 2020. https://www.fda.gov/news-events/press-announcements/fda-finalizes-enforcement-policy-unauthorized-flavored-cartridge-based-e-cigarettes-appeal-children. Accessed 21 Feb 2020.

  52. Alzahrani T, Pena I, Temesgen N, Glantz SA. Association between electronic cigarette use and myocardial infarction. Am J Prev Med. 2018;55(4):455–61. https://doi.org/10.1016/j.amepre.2018.05.004.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Glantz SA. The evidence of electronic cigarette risks is catching up with public perception. JAMA Netw Open. 2019;2(3):e191032. https://doi.org/10.1001/jamanetworkopen.2019.1032.

    Article  PubMed  Google Scholar 

  54. Kim SY, Sim S, Choi HG. Active, passive, and electronic cigarette smoking is associated with asthma in adolescents. Sci Rep. 2017;7(1):17789. https://doi.org/10.1038/s41598-017-17958-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. McConnell R, Barrington-Trimis JL, Wang K, Urman R, Hong H, Unger J, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med. 2017;195(8):1043–9. https://doi.org/10.1164/rccm.201604-0804OC.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Landman ST, Dhaliwal I, Mackenzie CA, Martinu T, Steele A, Bosma KJ. Life-threatening bronchiolitis related to electronic cigarette use in a Canadian youth. CMAJ. 2019;191(48):E1321–E31. https://doi.org/10.1503/cmaj.191402.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Henry TS, Kanne JP, Kligerman SJ. Imaging of vaping-associated lung disease. N Engl J Med. 2019;381(15):1486–7. https://doi.org/10.1056/NEJMc1911995.

    Article  PubMed  Google Scholar 

  58. Henry TS, Kligerman SJ, Raptis CA, Mann H, Sechrist JW, Kanne JP. Imaging findings of vaping-associated lung injury. AJR Am J Roentgenol. 2019:1–8. https://doi.org/10.2214/AJR.19.22251.

  59. Li L, Lin Y, Xia T, Zhu Y. Effects of electronic cigarettes on indoor air quality and health. Annu Rev Public Health. 2020. https://doi.org/10.1146/annurev-publhealth-040119-094043.

  60. Tzortzi A, Teloniatis S, Matiampa G, Bakelas G, Tzavara C, Vyzikidou VK, et al. Passive exposure of non-smokers to E-cigarette aerosols: sensory irritation, timing and association with volatile organic compounds. Environ Res. 2019;182:108963. https://doi.org/10.1016/j.envres.2019.108963.

    Article  CAS  PubMed  Google Scholar 

  61. McGrath-Morrow SA, Hayashi M, Aherrera A, Lopez A, Malinina A, Collaco JM, et al. The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PLoS One. 2015;10(2):e0118344. https://doi.org/10.1371/journal.pone.0118344.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Jones CD, Ho W, Gunn E, Widdowson D, Bahia H. E-cigarette burn injuries: comprehensive review and management guidelines proposal. Burns. 2019;45(4):763–71. https://doi.org/10.1016/j.burns.2018.09.015.

    Article  PubMed  Google Scholar 

  63. Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde M, et al. Pulmonary illness related to E-cigarette use in Illinois and Wisconsin - preliminary report. N Engl J Med. 2019. https://doi.org/10.1056/NEJMoa1911614.

  64. Schier JG, Meiman JG, Layden J, Mikosz CA, VanFrank B, King BA, et al. Severe pulmonary disease associated with electronic-cigarette-product use - Interim Guidance. MMWR Morb Mortal Wkly Rep. 2019;68(36):787–90. https://doi.org/10.15585/mmwr.mm6836e2.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Siegel DA, Jatlaoui TC, Koumans EH, Kiernan EA, Layer M, Cates JE, et al. Update: interim guidance for health care providers evaluating and caring for patients with suspected E-cigarette, or vaping, product use associated lung injury - United States, October 2019. MMWR Morb Mortal Wkly Rep. 2019;68(41):919–27. https://doi.org/10.15585/mmwr.mm6841e3.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Chatham-Stephens K, Roguski K, Jang Y, Cho P, Jatlaoui TC, Kabbani S, et al. Characteristics of hospitalized and nonhospitalized patients in a nationwide outbreak of E-cigarette, or vaping, product use-associated lung injury - United States, November 2019. MMWR Morb Mortal Wkly Rep. 2019;68(46):1076–80. https://doi.org/10.15585/mmwr.mm6846e1.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Lozier MJ, Wallace B, Anderson K, Ellington S, Jones CM, Rose D, et al. Update: demographic, product, and substance-use characteristics of hospitalized patients in a nationwide outbreak of E-cigarette, or vaping, product use-associated lung injuries - United States, December 2019. MMWR Morb Mortal Wkly Rep. 2019;68(49):1142–8. https://doi.org/10.15585/mmwr.mm6849e1.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Ellington S, Salvatore PP, Ko J, Danielson M, Kim L, Cyrus A, et al. Update: product, substance-use, and demographic characteristics of hospitalized patients in a nationwide outbreak of E-cigarette, or vaping, product use-associated lung injury - United States, August 2019–January 2020. MMWR Morb Mortal Wkly Rep. 2020;69(2):44–9. https://doi.org/10.15585/mmwr.mm6902e2.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Moritz ED, Zapata LB, Lekiachvili A, Glidden E, Annor FB, Werner AK, et al. Update: characteristics of patients in a national outbreak of E-cigarette, or vaping, product use-associated lung injuries - United States, October 2019. MMWR Morb Mortal Wkly Rep. 2019;68(43):985–9. https://doi.org/10.15585/mmwr.mm6843e1.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Blagev DP, Harris D, Dunn AC, Guidry DW, Grissom CK, Lanspa MJ. Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study. Lancet. 2019;394(10214):2073–83. https://doi.org/10.1016/S0140-6736(19)32679-0.

    Article  PubMed  Google Scholar 

  71. Bradford LE, Rebuli ME, Ring BJ, Jaspers I, Clement KC, Loughlin CE. Danger in the vapor? ECMO for adolescents with status asthmaticus after vaping. J Asthma. 2019:1–5. https://doi.org/10.1080/02770903.2019.1643361.

  72. Kalininskiy A, Bach CT, Nacca NE, Ginsberg G, Marraffa J, Navarette KA, et al. E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach. Lancet Respir Med. 2019;7(12):1017–26. https://doi.org/10.1016/S2213-2600(19)30415-1.

    Article  CAS  PubMed  Google Scholar 

  73. Chaumont M, Tagliatti V, Channan EM, Colet JM, Bernard A, Morra S, et al. Short halt in vaping modifies cardio-respiratory parameters and urine metabolome: a randomized trial. Am J Physiol Lung Cell Mol Physiol. 2019. https://doi.org/10.1152/ajplung.00268.2019.

  74. Williams C. Michigan teen receives double lung transplant after ‘enormous’ damage from vaping. Time. 2019. https://time.com/5726491/michigan-teen-vaping-damage-lung-transplant. Accessed 9 Dec 2019.

  75. Mikosz CA, Danielson M, Anderson KN, Pollack LA, Currie DW, Njai R, et al. Characteristics of patients experiencing rehospitalization or death after hospital discharge in a nationwide outbreak of E-cigarette, or vaping, product use-associated lung injury - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;68(5152):1183–8. https://doi.org/10.15585/mmwr.mm685152e1.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Thakrar PD, Boyd KP, Swanson CP, Wideburg E, Kumbhar SS. E-cigarette, or vaping, product use-associated lung injury in adolescents: a review of imaging features. Pediatr Radiol. 2020;50(3):338–44. https://doi.org/10.1007/s00247-019-04572-5.

    Article  PubMed  Google Scholar 

  77. Bonilla A, Blair AJ, Alamro SM, Ward RA, Feldman MB, Dutko RA, et al. Recurrent spontaneous pneumothoraces and vaping in an 18-year-old man: a case report and review of the literature. J Med Case Rep. 2019;13(1):283. https://doi.org/10.1186/s13256-019-2215-4.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Sajadi-Ernazarova KR, Martin J, Gupta N. Acute pneumothorax evaluation and treatment. Treasure Island: StatPearls; 2019.

    Google Scholar 

  79. Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, et al. Pulmonary lipid-laden macrophages and vaping. N Engl J Med. 2019;381(15):1488–9. https://doi.org/10.1056/NEJMc1912038.

    Article  PubMed  Google Scholar 

  80. Wu Q, Jiang D, Minor M, Chu HW. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One. 2014;9(9):e108342. https://doi.org/10.1371/journal.pone.0108342.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Saitman A, Park HD, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38(7):387–96. https://doi.org/10.1093/jat/bku075.

    Article  CAS  PubMed  Google Scholar 

  82. Navon L, Jones CM, Ghinai I, King BA, Briss PA, Hacker KA, et al. Risk factors for E-cigarette, or vaping, product use-associated lung injury (EVALI) among adults who use E-cigarette, or vaping, products - Illinois, July–October 2019. MMWR Morb Mortal Wkly Rep. 2019;68(45):1034–9. https://doi.org/10.15585/mmwr.mm6845e1.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Mukhopadhyay S, Mehrad M, Dammert P, Arrossi AV, Sarda R, Brenner DS, et al. Lung biopsy findings in severe pulmonary illness associated with E-cigarette use (Vaping). Am J Clin Pathol. 2020;153(1):30–9. https://doi.org/10.1093/ajcp/aqz182.

    Article  PubMed  Google Scholar 

  84. Blount BC, Karwowski MP, Shields PG, Morel-Espinosa M, Valentin-Blasini L, Gardner M, et al. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med. 2019. https://doi.org/10.1056/NEJMoa1916433.

  85. Butt YM, Smith ML, Tazelaar HD, Vaszar LT, Swanson KL, Cecchini MJ, et al. Pathology of vaping-associated lung injury. N Engl J Med. 2019;381(18):1780–1. https://doi.org/10.1056/NEJMc1913069.

    Article  PubMed  Google Scholar 

  86. New York State Department of Health announces update on investigation into vaping-associated pulmonary illnesses. New York State Department of Health. 2019. https://www.health.ny.gov/press/releases/2019/2019-09-05_vaping.htm. Accessed 29 Oct 2019.

  87. Duffy B, Li L, Lu S, Durocher L, Dittmar M, Delaney-Baldwin E, et al. Analysis of cannabinoid-containing fluids in illicit vaping cartridges recovered from pulmonary injury patients: identification of vitamin E acetate as a major diluent. Toxics. 2020;8(1). https://doi.org/10.3390/toxics8010008.

  88. Taylor J, Wiens T, Peterson J, Saravia S, Lunda M, Hanson K, et al. Characteristics of E-cigarette, or vaping, products used by patients with associated lung injury and products seized by law enforcement - Minnesota, 2018 and 2019. MMWR Morb Mortal Wkly Rep. 2019;68(47):1096–100. https://doi.org/10.15585/mmwr.mm6847e1.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Lewis N, McCaffrey K, Sage K, Cheng CJ, Green J, Goldstein L, et al. E-cigarette use, or vaping, practices and characteristics among persons with associated lung injury - Utah, April–October 2019. MMWR Morb Mortal Wkly Rep. 2019;68(42):953–6. https://doi.org/10.15585/mmwr.mm6842e1.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Lung illnesses associated with use of vaping products. U.S. Food & Drug Administration. 2019. https://www.fda.gov/news-events/public-health-focus/lung-illnesses-associated-use-vaping-products. Accessed 14 Dec 2019.

  91. Bhat TA, Kalathil SG, Bogner PN, Blount BC, Goniewicz ML, Thanavala YM. An animal model of inhaled vitamin E acetate and EVALI-like lung injury. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2000231.

  92. Wenzke M, Downs D. From ‘Veronica Mars’ to toxic vapes: the rise and fall of honey cut. Leafly. Leafly. 2019. https://www.leafly.com/news/health/toxic-vaping-vapi-evali-lung-injury-rise-and-fall-of-vitamin-e-oil-honey-cut. Accessed 6 Dec 2019.

  93. Downs D, Howard D, Barcott B. Journey of a tainted vape cartridge: from China’s labs to your lungs. Leafly. 2019. https://www.leafly.com/news/politics/vape-pen-injury-supply-chain-investigation-leafly. Accessed 6 Dec 2019.

  94. Drevon CA. Absorption, transport and metabolism of vitamin E. Free Radic Res Commun. 1991;14(4):229–46. https://doi.org/10.3109/10715769109088952.

    Article  CAS  PubMed  Google Scholar 

  95. Hung SS, Moon TW, Hilton JW, Slinger SJ. Uptake, transport and distribution of DL-alpha-tocopheryl acetate compared to D-alpha-tocopherol in rainbow trout (Salmo gairdneri). J Nutr. 1982;112(8):1590–9. https://doi.org/10.1093/jn/112.8.1590.

    Article  CAS  PubMed  Google Scholar 

  96. Mayer S, Weiss J, McClements DJ. Behavior of vitamin E acetate delivery systems under simulated gastrointestinal conditions: lipid digestion and bioaccessibility of low-energy nanoemulsions. J Colloid Interface Sci. 2013;404:215–22. https://doi.org/10.1016/j.jcis.2013.04.048.

    Article  CAS  PubMed  Google Scholar 

  97. Dan W, Donal OS. Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate. 2019.

  98. Fischer H, Widdicombe JH. Mechanisms of acid and base secretion by the airway epithelium. J Membr Biol. 2006;211(3):139–50. https://doi.org/10.1007/s00232-006-0861-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Hale TW, Rais-Bahrami K, Montgomery DL, Harkey C, Habersang RW. Vitamin E toxicity in neonatal piglets. J Toxicol Clin Toxicol. 1995;33(2):123–30. https://doi.org/10.3109/15563659509000461.

    Article  CAS  PubMed  Google Scholar 

  100. Lanzarotta A, Falconer TM, Flurer R, Wilson RA. Hydrogen bonding between tetrahydrocannabinol and vitamin E acetate in unvaped, aerosolized, and condensed aerosol e-liquids. Anal Chem. 2020;92(3):2374–8. https://doi.org/10.1021/acs.analchem.9b05536.

    Article  CAS  PubMed  Google Scholar 

  101. Richards JR. Cannabinoid hyperemesis syndrome: pathophysiology and treatment in the emergency department. J Emerg Med. 2018;54(3):354–63. https://doi.org/10.1016/j.jemermed.2017.12.010.

    Article  PubMed  Google Scholar 

  102. Victoria MS, Nangia BS. Hydrocarbon poisoning: a review. Pediatr Emerg Care. 1987;3(3):184–6. https://doi.org/10.1097/00006565-198709000-00014.

    Article  CAS  PubMed  Google Scholar 

  103. Meng Q, Buchanan B, Zuccolo J, Poulin MM, Gabriele J, Baranowski DC. A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products. PLoS One. 2018;13(5):e0196396. https://doi.org/10.1371/journal.pone.0196396.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Evans ME, Twentyman E, Click ES, Goodman AB, Weissman DN, Kiernan E, et al. Update: interim guidance for health care professionals evaluating and caring for patients with suspected E-cigarette, or vaping, product use-associated lung injury and for reducing the risk for rehospitalization and death following hospital discharge - United States, December 2019. MMWR Morb Mortal Wkly Rep. 2020;68(5152):1189–94. https://doi.org/10.15585/mmwr.mm685152e2.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dazhe James Cao.

Ethics declarations

Conflicts of Interest

None

Additional information

Supervising Editor: Michael Hodgman, MD

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cao, D.J., Aldy, K., Hsu, S. et al. Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury. J. Med. Toxicol. 16, 295–310 (2020). https://doi.org/10.1007/s13181-020-00772-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-020-00772-w

Keywords

Navigation